iShares Neuroscience and Healthcare ETF (IBRN) Institutional Ownership $25.47 +0.10 (+0.39%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatings Institutional Ownership Changes (13F Filings) for iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$253.95KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$190.38K Get IBRN Insider Trade Alerts Want to know when executives and insiders are buying or selling iShares Neuroscience and Healthcare ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol iShares Neuroscience and Healthcare ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Jane Street Group LLC10,150$254K0.0%N/A6.767% 11/14/2024 Flow Traders U.S. LLC9,762$244K0.0%-43.8%6.508% 8/9/2023 Flow Traders U.S. LLC32,822$798K0.0%-11.8%16.411% (Data available from 1/1/2016 forward) IBRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IBRN shares? During the previous two years, the following institutional investors and hedge funds held shares of iShares Neuroscience and Healthcare ETF shares: Jane Street Group LLC ($254K), Flow Traders U.S. LLC ($244K).Learn more on IBRN's institutional investors. Which institutional investors have been buying iShares Neuroscience and Healthcare ETF stock? The following institutional investors have purchased iShares Neuroscience and Healthcare ETF stock in the last 24 months: Jane Street Group LLC ($10.15K). How much institutional buying is happening at iShares Neuroscience and Healthcare ETF? Institutional investors have bought a total of 10,150 shares in the last 24 months. This purchase volume represents approximately $253.95K in transactions. Which iShares Neuroscience and Healthcare ETF major shareholders have been selling company stock? The following institutional investors have sold iShares Neuroscience and Healthcare ETF stock in the last 24 months: Flow Traders U.S. LLC ($11.98K). How much institutional selling is happening at iShares Neuroscience and Healthcare ETF? Institutional investors have sold a total of 11,980 shares in the last 24 months. This volume of shares sold represents approximately $296.59K in transactions. Related Companies First Trust Indxx Metaverse ETF Institutional Ownership Veridien Climate Action ETF Institutional Ownership AGF Global Infrastructure ETF Institutional Ownership Amplify Weight Loss Drug & Treatment ETF Institutional Ownership First Trust S-Network Streaming and Gaming ETF Institutional Ownership AdvisorShares Restaurant ETF Institutional Ownership Harbor Disruptive Innovation ETF Institutional Ownership ProShares Decline of the Retail Store ETF Institutional Ownership KraneShares MSCI One Belt One Road ETF Institutional Ownership Global X AgTech & Food Innovation ETF Institutional Ownership This page (NYSEARCA:IBRN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
